A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

BGNE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $568,875,239.08

BeiGene Insider Trading History Chart

BeiGene Share Price & Price History

^$129.52

▼ -2.44 (-1.85%)

As of 04/19/2024 01:00 AM ET

Days: 30 | 90 | 365

SHOCKING Crypto Leak…

From Crypto 101 Media | Ad

Claim your free seat by clicking here now.

BeiGene Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/10/2024	John Oyler	CEO	Sell	26,716	$148.89	$3,977,745.24	12,084
3/12/2024	John Oyler	CEO	Sell	37,668	$164.02	$6,178,305.36	12,332
2/29/2024	Julia Aijun Wang	CFO	Sell	397	$167.08	$66,330.76
7/31/2023	Chan Henry Lee	SVP	Sell	791	$216.26	$171,061.66
7/3/2023	Julia Aijun Wang	CFO	Sell	472	$179.55	$84,747.60
6/26/2023	Lai Wang	insider	Sell	1,108	$181.92	$201,567.36
6/26/2023	Xiaobin Wu	COO	Sell	1,495	$182.37	$272,643.15
6/23/2023	Corazon (Corsee) D. Sanders	Director	Sell	578	$182.32	$105,380.96
6/23/2023	Julia Aijun Wang	CFO	Sell	840	$182.85	$153,594.00
6/20/2023	Lai Wang	insider	Sell	1,325	$192.42	$254,956.50
6/14/2023	Advisors Ltd. Hhlr	Major Shareholder	Sell	273,728	$207.72	$56,858,780.16	142,888,241
6/12/2023	Advisors Ltd. Hhlr	Major Shareholder	Sell	1,250,212	$195.21	$244,053,884.52	144,086,369
6/8/2023	Advisors Ltd. Hhlr	Major Shareholder	Sell	1,163,825	$218.14	$253,876,785.50	145,879,233
6/7/2023	Lai Wang	insider	Sell	462	$224.74	$103,829.88
6/7/2023	Xiaobin Wu	COO	Sell	3,291	$224.73	$739,586.43
5/8/2023	Xiaobin Wu	COO	Sell	7,000	$253.72	$1,776,040.00
3/8/2023	Xiaodong Wang	insider	Sell	67,635	$226.03	$15,287,539.05
1/11/2023	Xiaodong Wang	insider	Sell	2,500	$252.66	$631,650.00	5,512,556
1/10/2023	John Oyler	CEO	Sell	6,797	$248.52	$1,689,190.44
1/9/2023	Xiaodong Wang	insider	Sell	900	$250.00	$225,000.00
12/29/2022	John Oyler	CEO	Sell	1,716	$224.46	$385,173.36
12/27/2022	John Oyler	CEO	Sell	1,120	$224.29	$251,204.80
12/13/2022	Xiaodong Wang	Insider	Sell	3,013	$211.33	$636,737.29	5,577,556
11/15/2022	John Oyler	CEO	Sell	25,000	$206.84	$5,171,000.00
11/15/2022	Xiaodong Wang	Insider	Sell	1,987	$210.14	$417,548.18	5,629,556
9/20/2022	John Oyler	CEO	Sell	30,520	$153.50	$4,684,820.00	2,070,913
7/1/2022	Julia Aijun Wang	CFO	Sell	295	$158.50	$46,757.50
6/27/2022	Lai Wang	insider	Sell	458	$177.32	$81,212.56
6/21/2022	Lai Wang	insider	Sell	723	$149.01	$107,734.23
6/21/2022	Xiaobin Wu	COO	Sell	1,010	$144.36	$145,803.60
6/17/2022	Julia Aijun Wang	CFO	Sell	161	$136.64	$21,999.04
6/17/2022	Lai Wang	Insider	Sell	445	$139.40	$62,033.00	723
6/17/2022	Xiaobin Wu	COO	Sell	578	$139.60	$80,688.80	1,010
6/6/2022	Lai Wang	insider	Sell	660	$142.00	$93,720.00
6/6/2022	Xiaobin Wu	COO	Sell	3,410	$141.99	$484,185.90
5/5/2022	Xiaobin Wu	COO	Sell	6,725	$164.35	$1,105,253.75
12/14/2021	Jane Huang	CMO	Sell	1,500	$278.14	$417,210.00
12/1/2021	Jane Huang	CMO	Sell	1,049	$359.86	$377,493.14
11/17/2021	Jane Huang	CMO	Sell	1,500	$381.34	$572,010.00
10/19/2021	Jane Huang	CMO	Sell	1,500	$372.78	$559,170.00
9/24/2021	Ltd. Beigene	Major Shareholder	Buy	2,543,800	$2.85	$7,249,830.00
9/20/2021	Jane Huang	CMO	Sell	6,000	$397.96	$2,387,760.00
9/14/2021	John Oyler	CEO	Sell	195,477	$93.87	$18,349,425.99	2,267,161
9/13/2021	Jane Huang	CMO	Sell	12,901	$358.14	$4,620,364.14	145,235
9/10/2021	Amgen Inc	Major Shareholder	Buy	165,529	$302.06	$49,999,689.74
9/2/2021	John Oyler	CEO	Sell	24,499	$328.21	$8,040,816.79	3,694,720
9/1/2021	Jane Huang	CMO	Sell	542	$310.53	$168,307.26	305,824
8/31/2021	John Oyler	CEO	Sell	111,081	$110.13	$12,233,350.53
8/4/2021	John Oyler	CEO	Sell	80,847	$150.97	$12,205,471.59	4,385,979
7/22/2021	John Oyler	CEO	Sell	69,216	$71.82	$4,971,093.12	5,849,945
7/20/2021	John Oyler	CEO	Sell	43,695	$132.26	$5,779,100.70	5,849,945
7/15/2021	Jane Huang	CMO	Sell	21,000	$332.42	$6,980,820.00	298,661
7/7/2021	John Oyler	CEO	Sell	300	$325.23	$97,569.00
7/6/2021	Xiaobin Wu	COO	Sell	10,180	$325.53	$3,313,895.40	1,081,389
7/1/2021	Julia Aijun Wang	CFO	Sell	308	$349.06	$107,510.48
6/28/2021	Howard Liang	CFO	Sell	446	$365.00	$162,790.00	1,553,149
6/28/2021	Lai Wang	Insider	Sell	455	$362.48	$164,928.40
6/18/2021	Xiaobin Wu	COO	Sell	1,156	$330.93	$382,555.08
6/9/2021	Timothy Yung-Cheng Chen	Director	Sell	3,164	$351.35	$1,111,671.40	3,164
6/7/2021	Howard Liang	CFO	Sell	650	$354.16	$230,204.00	1,565,265
6/7/2021	Jane Huang	CMO	Sell	603	$351.55	$211,984.65	284,933
6/7/2021	Lai Wang	Insider	Sell	656	$354.26	$232,394.56	195,455
6/7/2021	Xiaobin Wu	COO	Sell	3,398	$352.54	$1,197,930.92	1,150,757
6/1/2021	Jane Huang	CMO	Sell	540	$362.64	$195,825.60	292,772
5/28/2021	Jane Huang	CMO	Sell	1,500	$356.30	$534,450.00	292,772
5/10/2021	Xiaodong Wang	Insider	Sell	3,394	$300.46	$1,019,761.24	5,747,271
5/3/2021	Xiaobin Wu	COO	Sell	6,715	$343.00	$2,303,245.00
4/29/2021	Jane Huang	CMO	Sell	1,500	$354.92	$532,380.00	285,583

The “Perfect Storm” for Gold

From Gold Safe Exchange | Ad

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

SEC Filings (Institutional Ownership Changes) for BeiGene (NASDAQ:BGNE)

48.55% of BeiGene stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BeiGene Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/18/2024	LVW Advisors LLC	1,957	$0.31M	0.1%	+50.2%	0.002%
3/22/2024	PNC Financial Services Group Inc.	411	$74K	0.0%	-43.9%	0.000%
3/1/2024	Goldman Sachs Group Inc.	214,339	$38.66M	0.0%	+175.2%	0.225%
2/26/2024	Virtu Financial LLC	5,319	$0.96M	0.1%	+94.2%	0.006%
2/15/2024	Exome Asset Management LLC	12,800	$2.31M	2.3%	N/A	0.013%
2/15/2024	Virtus ETF Advisers LLC	1,739	$0.31M	0.2%	+19.2%	0.002%
2/15/2024	Legal & General Group Plc	74,886	$13.51M	0.0%	-28.5%	0.078%
2/15/2024	Old Well Partners LLC	9,638	$1.74M	1.6%	-49.7%	0.010%
2/15/2024	Price T Rowe Associates Inc. MD	1,908,189	$344.16M	0.0%	+9.1%	2.000%
2/15/2024	Profund Advisors LLC	6,425	$1.16M	0.0%	+24.6%	0.007%
2/15/2024	Parkwood LLC	6,464	$1.17M	0.1%	+3.0%	0.007%
2/15/2024	Baird Financial Group Inc.	164,933	$29.75M	0.1%	+26.4%	0.173%
2/14/2024	Royal Bank of Canada	56,252	$10.15M	0.0%	-6.5%	0.059%
2/14/2024	ADAR1 Capital Management LLC	2,028	$0.37M	0.1%	N/A	0.002%
2/14/2024	Point72 Hong Kong Ltd	1,100	$0.20M	0.0%	N/A	0.001%
2/14/2024	Cubist Systematic Strategies LLC	30,096	$5.43M	0.0%	N/A	0.032%
2/14/2024	Bellevue Group AG	28,600	$5.21M	0.1%	-46.2%	0.030%
2/14/2024	Sei Investments Co.	59,394	$10.71M	0.0%	-7.0%	0.062%
2/14/2024	Sectoral Asset Management Inc.	3,752	$0.68M	0.3%	+12.6%	0.004%
2/14/2024	Schroder Investment Management Group	12,700	$2.29M	0.0%	N/A	0.013%
2/13/2024	Envestnet Asset Management Inc.	49,365	$8.90M	0.0%	+5.7%	0.052%
2/13/2024	Northern Trust Corp	9,228	$1.66M	0.0%	+6.0%	0.010%
2/13/2024	Crossmark Global Holdings Inc.	4,078	$0.74M	0.0%	-3.7%	0.004%
2/13/2024	Tower Research Capital LLC TRC	2,024	$0.37M	0.0%	+435.4%	0.002%
2/13/2024	Capital International Sarl	176,337	$31.80M	1.2%	+6.5%	0.185%
2/13/2024	Capital International Ltd. CA	65,661	$11.84M	0.6%	+3.3%	0.069%
2/13/2024	Capital International Investors	6,336,872	$1.14B	0.3%	+4.7%	6.640%
2/13/2024	First Trust Advisors LP	219,741	$39.63M	0.0%	N/A	0.230%
2/13/2024	Goldman Sachs Group Inc.	214,339	$38.66M	0.0%	+175.2%	0.225%
2/13/2024	NEOS Investment Management LLC	2,442	$0.44M	0.0%	N/A	0.003%
2/13/2024	The Manufacturers Life Insurance Company	39,759	$7.17M	0.0%	+15.4%	0.042%
2/13/2024	KBC Group NV	8,937	$1.61M	0.0%	-21.3%	0.009%
2/13/2024	Campbell & CO Investment Adviser LLC	7,313	$1.32M	0.1%	N/A	0.008%
2/12/2024	Partners Capital Investment Group LLP	15,316	$2.76M	0.1%	N/A	0.016%
2/12/2024	Qtron Investments LLC	1,378	$0.25M	0.0%	-17.7%	0.001%
2/12/2024	Axiom Investors LLC DE	83,985	$15.15M	0.1%	-4.3%	0.088%
2/12/2024	Stifel Financial Corp	12,457	$2.25M	0.0%	-2.8%	0.013%
2/12/2024	TD Asset Management Inc	101,663	$18.34M	0.0%	+1.4%	0.107%
2/12/2024	Steward Partners Investment Advisory LLC	694	$0.13M	0.0%	+73.5%	0.001%
2/12/2024	Hsbc Holdings PLC	31,778	$5.72M	0.0%	-51.5%	0.033%
2/9/2024	Primecap Management Co. CA	4,988,639	$899.75M	0.7%	-0.4%	5.231%
2/9/2024	Aigen Investment Management LP	1,635	$0.30M	0.1%	N/A	0.002%
2/9/2024	Assetmark Inc.	11,896	$2.15M	0.0%	+13.4%	0.012%
2/9/2024	BNP Paribas Asset Management Holding S.A.	102,970	$18.57M	0.1%	+7.4%	0.108%
2/9/2024	Trexquant Investment LP	6,090	$1.10M	0.0%	N/A	0.006%
2/9/2024	Wells Fargo & Company MN	49,036	$8.84M	0.0%	-3.8%	0.051%
2/9/2024	UBS Group AG	7,511	$1.36M	0.0%	-72.5%	0.008%
2/9/2024	PNC Financial Services Group Inc.	411	$74K	0.0%	-43.9%	0.000%
2/9/2024	BI Asset Management Fondsmaeglerselskab A S	1,012	$0.18M	0.0%	N/A	0.001%
2/9/2024	Dynamic Technology Lab Private Ltd	1,190	$0.22M	0.0%	N/A	0.001%
2/9/2024	Norges Bank	27,477	$4.96M	0.0%	N/A	0.029%
2/8/2024	NINE MASTS CAPITAL Ltd	14,612	$2.68M	2.0%	+374.9%	0.015%
2/8/2024	Fiera Capital Corp	8,380	$1.51M	0.0%	-2.3%	0.009%
2/8/2024	EFG Asset Management North America Corp.	9,926	$1.79M	0.3%	-4.3%	0.010%
2/8/2024	Barings LLC	60,379	$10.89M	0.3%	N/A	0.063%
2/8/2024	Janney Montgomery Scott LLC	1,393	$0.25M	0.0%	-6.7%	0.001%
2/8/2024	Vanguard Personalized Indexing Management LLC	1,253	$0.23M	0.0%	-26.5%	0.001%
2/8/2024	M&G Investment Management Ltd.	173,266	$31.19M	0.2%	+4.4%	0.182%
2/7/2024	Dimensional Fund Advisors LP	11,289	$2.04M	0.0%	-1.7%	0.012%
2/7/2024	Jump Financial LLC	1,961	$0.35M	0.0%	N/A	0.002%
2/7/2024	BNP Paribas Financial Markets	59,307	$10.70M	0.0%	+7,724.1%	0.062%
2/6/2024	Vestmark Advisory Solutions Inc.	1,601	$0.29M	0.0%	+9.5%	0.002%
2/6/2024	Benjamin F. Edwards & Company Inc.	542	$98K	0.0%	N/A	0.001%
2/6/2024	First Trust Direct Indexing L.P.	2,808	$0.51M	0.0%	-13.4%	0.003%
2/5/2024	Van ECK Associates Corp	82,696	$14.92M	0.0%	-15.7%	0.087%
2/5/2024	Russell Investments Group Ltd.	6,650	$1.20M	0.0%	-5.9%	0.007%
2/1/2024	Handelsbanken Fonder AB	21,280	$3.84M	0.0%	-23.5%	0.022%
2/1/2024	OVERSEA CHINESE BANKING Corp Ltd	7,412	$1.34M	0.0%	-23.1%	0.008%
1/31/2024	abrdn plc	21,138	$3.81M	0.0%	+1,346.8%	0.022%
1/31/2024	AIA Group Ltd	13,316	$2.40M	0.1%	+13.8%	0.014%
1/31/2024	Daiwa Securities Group Inc.	172	$31K	0.0%	-87.1%	0.000%
1/29/2024	Simplicity Solutions LLC	3,700	$0.67M	0.0%	-3.3%	0.004%
1/29/2024	NewEdge Wealth LLC	1,612	$0.29M	0.0%	+7.5%	0.002%
1/26/2024	Cerity Partners LLC	2,174	$0.39M	0.0%	-4.3%	0.002%
1/26/2024	Baillie Gifford & Co.	3,866,449	$697.35M	0.6%	-0.1%	4.055%
1/25/2024	Bleakley Financial Group LLC	3,719	$0.67M	0.0%	-2.8%	0.004%
1/24/2024	DekaBank Deutsche Girozentrale	13,600	$2.43M	0.0%	-54.1%	0.014%
1/24/2024	China Universal Asset Management Co. Ltd.	4,856	$0.88M	0.2%	+350.5%	0.005%
1/19/2024	JGP Global Gestao de Recursos Ltda.	9,845	$1.78M	1.7%	+135.5%	0.010%
1/18/2024	Clear Harbor Asset Management LLC	1,155	$0.21M	0.0%	N/A	0.001%
1/17/2024	Matthews International Capital Management LLC	20,902	$3.77M	0.5%	-65.7%	0.022%
1/16/2024	Raymond James & Associates	12,597	$2.27M	0.0%	-3.7%	0.013%
1/16/2024	LVW Advisors LLC	1,303	$0.24M	0.0%	-12.6%	0.001%
1/12/2024	SG Americas Securities LLC	698	$0.13M	0.0%	-19.4%	0.001%
1/5/2024	Harbour Capital Advisors LLC	2,545	$0.46M	0.1%	-6.9%	0.003%
12/6/2023	Citigroup Inc.	2,759	$0.50M	0.0%	-15.2%	0.003%
12/1/2023	Wellington Management Group LLP	55,478	$9.98M	0.0%	+57.4%	0.058%
11/24/2023	Deutsche Bank AG	19,607	$3.53M	0.0%	-8.2%	0.021%
11/16/2023	Tudor Investment Corp Et Al	1,600	$0.29M	0.0%	N/A	0.002%
11/16/2023	Morgan Stanley	145,582	$26.19M	0.0%	-19.7%	0.153%
11/15/2023	The Manufacturers Life Insurance Company	34,455	$6.20M	0.0%	+2.8%	0.036%
11/15/2023	Royal Bank of Canada	60,185	$10.82M	0.0%	-4.7%	0.063%
11/15/2023	Sectoral Asset Management Inc.	3,332	$0.60M	0.1%	-42.6%	0.003%
11/15/2023	Sei Investments Co.	63,844	$11.48M	0.0%	-11.0%	0.067%
11/15/2023	Legal & General Group Plc	104,710	$18.83M	0.0%	+12.6%	0.110%
11/15/2023	Advisors Asset Management Inc.	1,062	$0.19M	0.0%	+20.8%	0.001%
11/15/2023	Alberta Investment Management Corp	8,570	$1.54M	0.0%	+214.3%	0.009%
11/14/2023	Old Well Partners LLC	19,165	$3.45M	3.0%	-7.3%	0.020%
11/14/2023	Toronto Dominion Bank	333	$60K	0.0%	+166.4%	0.000%
11/14/2023	Tower Research Capital LLC TRC	378	$68K	0.0%	-90.2%	0.000%

Data available starting January 2016

BeiGene, Ltd., through its subsidiaries, engages in the development and commercialization of oncology medicines worldwide. Its products include BRUKINSA to treat various blood cancers; TEVIMBRA to treat various solid tumor and blood cancers; PARTRUVIX for the treatment of various solid tumor malignancies; XGEVA to treat bone metastases from solid tumors and multiple myeloma, as well as giant cell tumor of bone; BLINCYTO to treat acute lymphoblastic leukemia; KYPROLIS to treat R/R multiple myeloma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; SYLVANT to treat idiopathic multicentric castleman disease; QARZIBA to treat neuroblastoma; POBEVCY to treat metastatic colorectal cancer, liver cancer, and non-small cell lung cancer (NSCLC); BAITUOWEI, to treat breast and prostate cancers; TAFINLAR and MEKINIST to treat NSCLC and melanoma; VOTRIENT for advance renal cell carcinoma; AFINITOR for advance renal cell carcinoma, NET, SEGA, & breast cancers; and ZYKADIA to treat ALK + NSCLC. The company is also developing inhibitors comprising Sonrotoclax (BGB-11417), BGB-10188, BGB-21447, Ociperlimab (BGB-A1217), Surzebiclimab (BGB-A425), BGB-15025, BGB-26808, Lifirafenib (BGB-283), BGB-3245, BGB-30813, and BGB-43395; antibodies, including Zanidatamab, BGB-A445, and BGB-A3055, as well as BGB-16673, a BTK-targeted CDAC, and BGB-24714, a SMAC mimetic. It has collaborations with Shoreline Biosciences, Inc., Amgen Inc., Novartis AG, Bristol Myers Squibb company, Shandong Luye Pharmaceutical Co., Ltd., Nanjing Leads Biolabs, Inc., EUSA Pharma, Assembly Biosciences, Inc., Bio-Thera Solutions, Ltd., and Nanjing Leads Biolabs Co., Ltd. The company was incorporated in 2010 and is based in Grand Cayman, the Cayman Islands.

Today's Range

Now: $129.52

$126.97

$130.85

50 Day Range

MA: $155.43

$131.86

$179.69

52 Week Range

Now: $129.52

$126.97

$266.67

Volume

296,406 shs

Average Volume

260,071 shs

Market Capitalization

$12.39 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.61

Who are the company insiders with the largest holdings of BeiGene?: BeiGene's top insider investors include:
Advisors Ltd Hhlr (Major Shareholder)
Xiaodong Wang (Insider)
John Oyler (CEO)
Xiaobin Wu (COO)
Lai Wang (Insider)
Chan Henry Lee (SVP)
Corazon (Corsee) D Sanders (Director)
Julia Aijun Wang (CFO)
Learn More about top insider investors at BeiGene.
Who are the major institutional investors of BeiGene?: BeiGene's top institutional shareholders include:
LVW Advisors LLC — 0.00%
Learn More about top institutional investors of BeiGene stock.
Which major investors are buying BeiGene stock?: During the last quarter, BGNE stock was bought by institutional investors including:
LVW Advisors LLC

SHOCKING Crypto Leak…

From Crypto 101 Media | Ad

Claim your free seat by clicking here now.

BGNE Insider Trading

BeiGene Insider Trading History Chart

BeiGene Share Price & Price History

BeiGene Insider Trading History

SEC Filings (Institutional Ownership Changes) for BeiGene (NASDAQ:BGNE)

Institutional Buying and Selling by Quarter

BeiGene Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of BeiGene?

Who are the major institutional investors of BeiGene?

Which major investors are buying BeiGene stock?